Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AOTG NASDAQ:CANC NASDAQ:ENTR NASDAQ:XAIX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAOTGAOT Growth & Innovation ETF$57.51+1.8%$53.92$32.95▼$57.92$83.97M-1.845,660 shs9,379 shsCANCTema Oncology ETF$30.05+0.9%$28.10$20.10▼$30.64$83.83M1.1114,113 shs3,451 shsENTRERShares Entrepreneurs ETF$15.31-1.0%$15.13$10.71▼$16.00$84.21M1.154,295 shs300 shsXAIXXtrackers Artificial Intelligence and Big Data ETF$43.29+1.6%$40.72$26.95▼$43.33$88.30MN/A25,552 shs12,268 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAOTGAOT Growth & Innovation ETF+1.81%+3.62%+6.36%+10.23%+35.54%CANCTema Oncology ETF+0.92%-0.28%+10.32%+11.53%+8.31%ENTRERShares Entrepreneurs ETF0.00%0.00%0.00%0.00%0.00%XAIXXtrackers Artificial Intelligence and Big Data ETF+1.62%+2.83%+4.34%+11.29%+34.07%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAOTGAOT Growth & Innovation ETF$57.51+1.8%$53.92$32.95▼$57.92$83.97M-1.845,660 shs9,379 shsCANCTema Oncology ETF$30.05+0.9%$28.10$20.10▼$30.64$83.83M1.1114,113 shs3,451 shsENTRERShares Entrepreneurs ETF$15.31-1.0%$15.13$10.71▼$16.00$84.21M1.154,295 shs300 shsXAIXXtrackers Artificial Intelligence and Big Data ETF$43.29+1.6%$40.72$26.95▼$43.33$88.30MN/A25,552 shs12,268 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAOTGAOT Growth & Innovation ETF+1.81%+3.62%+6.36%+10.23%+35.54%CANCTema Oncology ETF+0.92%-0.28%+10.32%+11.53%+8.31%ENTRERShares Entrepreneurs ETF0.00%0.00%0.00%0.00%0.00%XAIXXtrackers Artificial Intelligence and Big Data ETF+1.62%+2.83%+4.34%+11.29%+34.07%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAOTGAOT Growth & Innovation ETF 2.80Moderate Buy$57.51N/ACANCTema Oncology ETF 2.77Moderate Buy$30.05N/AENTRERShares Entrepreneurs ETF 2.66Moderate Buy$15.31N/AXAIXXtrackers Artificial Intelligence and Big Data ETF 2.75Moderate Buy$43.29N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAOTGAOT Growth & Innovation ETFN/AN/AN/AN/AN/AN/ACANCTema Oncology ETFN/AN/AN/AN/AN/AN/AENTRERShares Entrepreneurs ETFN/AN/AN/AN/AN/AN/AXAIXXtrackers Artificial Intelligence and Big Data ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAOTGAOT Growth & Innovation ETFN/AN/A43.07∞N/AN/AN/AN/AN/ACANCTema Oncology ETFN/AN/A20.39∞N/AN/AN/AN/AN/AENTRERShares Entrepreneurs ETFN/A-$0.89N/A∞N/AN/AN/AN/AN/AXAIXXtrackers Artificial Intelligence and Big Data ETFN/AN/A24.06∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAOTGAOT Growth & Innovation ETFN/AN/AN/AN/AN/ACANCTema Oncology ETF$0.722.40%N/AN/AN/AENTRERShares Entrepreneurs ETF$8.7256.96%N/AN/A N/AXAIXXtrackers Artificial Intelligence and Big Data ETF$0.130.30%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAOTGAOT Growth & Innovation ETFN/ACANCTema Oncology ETFN/AENTRERShares Entrepreneurs ETF58.66%XAIXXtrackers Artificial Intelligence and Big Data ETFN/AInsider OwnershipCompanyInsider OwnershipAOTGAOT Growth & Innovation ETFN/ACANCTema Oncology ETFN/AENTRERShares Entrepreneurs ETF4.96%XAIXXtrackers Artificial Intelligence and Big Data ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAOTGAOT Growth & Innovation ETFN/A1.46 millionN/ANot OptionableCANCTema Oncology ETFN/A2.79 millionN/ANot OptionableENTRERShares Entrepreneurs ETFN/A19.45 millionN/AN/AXAIXXtrackers Artificial Intelligence and Big Data ETFN/A2.04 millionN/AN/AENTR, AOTG, CANC, and XAIX HeadlinesRecent News About These CompaniesAIQ: What Real Exposure To AI And Big Data Looks Like In An ETFOctober 14, 2025 | seekingalpha.comETF 360: Xtrackers by DWS on Geopolitics, Risk, AI & MoreJuly 25, 2025 | etftrends.comEWant AI Exposure? These 3 ETFs Offer Different Angles (XAIX)...June 9, 2025 | marketbeat.comXtrackers Artificial Intelligence & Big Data ETFJune 5, 2025 | marketwatch.comXtrackers Artificial Intelligence and Big Data ETF (XAIX)May 6, 2025 | finance.yahoo.comThe Smartest Artificial Intelligence (AI) ETF to Buy With $1,000 Right NowApril 7, 2025 | fool.comETFs for Artificial Intelligence's Broadening ReachNovember 22, 2024 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 20255 Stocks Congress Quietly Bought in Q3—Should You Follow?By Thomas Hughes | October 10, 2025Top 3 Dividend Achievers for October: High Yields, Growth AheadBy Thomas Hughes | October 1, 2025Cheap Chipotle? Why CMG Stock Could Be Ready for a ComebackBy Sam Quirke | October 4, 2025Best Way to Invest in Gold Right Now—What Smart Money Is DoingBy Jeffrey Neal Johnson | October 23, 2025ENTR, AOTG, CANC, and XAIX Company DescriptionsAOT Growth & Innovation ETF NASDAQ:AOTG$57.51 +1.02 (+1.81%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$57.52 +0.01 (+0.02%) As of 10/24/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AOT Growth and Innovation ETF (AOTG) is an exchange-traded fund that mostly invests in total market equity. The fund actively invests in a growth portfolio of low marginal cost companies in the US. Stocks are selected based on proprietary fundamental research and criteria. AOTG was launched on Jun 29, 2022 and is managed by Alpha Architect.Tema Oncology ETF NASDAQ:CANC$30.05 +0.27 (+0.89%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$30.04 0.00 (0.00%) As of 10/24/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.ERShares Entrepreneurs ETF NASDAQ:ENTRThe ERShares Entrepreneurs ETF (ENTR) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed fund that seeks to invest in US-listed entrepreneurial firms. The fund adviser uses a proprietary machine learning model to evaluate securities. ENTR was launched on Nov 7, 2017 and is issued by ERShares.Xtrackers Artificial Intelligence and Big Data ETF NASDAQ:XAIX$43.29 +0.69 (+1.62%) As of 10/24/2025 03:58 PM EasternThe Xtrackers Artificial Intelligence and Big Data ETF (XAIX) is an exchange-traded fund that is based on the Nasdaq Global AI and Big Data index. The fund tracks a market cap-weighted index of companies with exposure to the broad theme of artificial intelligence and big data. The funds selection process considers its tie to specific sub-themes and various factors. XAIX was launched on Aug 2, 2024 and is issued by Xtrackers. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 10/20 - 10/24 Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tractor Supply Stock Looks Like a Buy-and-Hold Winner Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Fal.Con Europe Could Be CrowdStrike’s Early Earnings Catalyst Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
